Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration, United States
Disclosure information not submitted.
Assessment of non-cardiac congenital malformations and in utero exposure to modafinil/armodafinil in the Sentinel Distributed Database
Tuesday, August 27, 20249:00 AM – 9:15 AM CEST
